Concurrent chemoradiotherapy in non-small cell lung cancer
about
PET-CT for assessing mediastinal lymph node involvement in patients with suspected resectable non-small cell lung cancerPET-CT for assessing mediastinal lymph node involvement in patients with suspected resectable non-small cell lung cancerBPIQ, a novel synthetic quinoline derivative, inhibits growth and induces mitochondrial apoptosis of lung cancer cells in vitro and in zebrafish xenograft modelDual roles of extracellular signal-regulated kinase (ERK) in quinoline compound BPIQ-induced apoptosis and anti-migration of human non-small cell lung cancer cellsComparison of toxicity and outcomes of concurrent radiotherapy with carboplatin/paclitaxel or cisplatin/etoposide in stage III non-small cell lung cancer.A phase I study of nedaplatin, pemetrexed and thoracic intensity-modulated radiotherapy for inoperable stage III lung adenocarcinomaLong-term outcomes after salvage radiotherapy for postoperative locoregionally recurrent non-small-cell lung cancerIntratumoral Metabolic Heterogeneity for Prediction of Disease Progression After Concurrent Chemoradiotherapy in Patients with Inoperable Stage III Non-Small-Cell Lung Cancer.Preliminary analysis of the risk factors for radiation pneumonitis in patients with non-small-cell lung cancer treated with concurrent erlotinib and thoracic radiotherapyCombined modality therapy in Stage IIIA non-small cell lung cancer: clarity or confusion despite the highest level of evidence?Poor prognosis patients with inoperable locally advanced NSCLC and large tumors benefit from palliative chemoradiotherapy: a subset analysis from a randomized clinical phase III trial.INSPIRE: A phase III study of the BLP25 liposome vaccine (L-BLP25) in Asian patients with unresectable stage III non-small cell lung cancerInflammation-related genetic variants predict toxicity following definitive radiotherapy for lung cancerConcurrent gemcitabine and 3D radiotherapy in patients with stage III unresectable non-small cell lung cancer.Concurrent chemoradiotherapy for locally advanced breast cancer-time for a new paradigm?Functional lung avoidance for individualized radiotherapy (FLAIR): study protocol for a randomized, double-blind clinical trialRole of HGF/MET axis in resistance of lung cancer to contemporary management.A phase I trial of the HIV protease inhibitor nelfinavir with concurrent chemoradiotherapy for unresectable stage IIIA/IIIB non-small cell lung cancer: a report of toxicities and clinical response.Treatment-Related Death during Concurrent Chemoradiotherapy for Locally Advanced Non-Small Cell Lung Cancer: A Meta-Analysis of Randomized StudiesChanges of acute-phase protein levels in the serum of lung cancer patients following radiotherapyFeasibility, tolerability, and efficacy of the concurrent addition of erlotinib to thoracic radiotherapy in locally advanced unresectable non-small-cell lung cancer: a Phase II trial.Fludarabine combined with radiotherapy in patients with locally advanced NSCLC lung carcinoma: a phase I study.DNA damage response (DDR) pathway engagement in cisplatin radiosensitization of non-small cell lung cancer.Marital status and survival in patients with cancer.Phase III study of cisplatin with pemtrexed or vinorelbine plus concurrent late course accelerated hyperfractionated radiotherapy in patients with unresectable stage III non-small cell lung cancer.Validation and optimization of a predictive model for radiation pneumonitis in patients with lung cancerIDEAL-CRT: A Phase 1/2 Trial of Isotoxic Dose-Escalated Radiation Therapy and Concurrent Chemotherapy in Patients With Stage II/III Non-Small Cell Lung Cancer.Concurrent palliative chemoradiation leads to survival and quality of life benefits in poor prognosis stage III non-small-cell lung cancer: a randomised trial by the Norwegian Lung Cancer Study Group.Inhibitory effect of trans-ferulic acid on proliferation and migration of human lung cancer cells accompanied with increased endogenous reactive oxygen species and β-catenin instabilityComparison between concurrent and sequential chemoradiation for non-small cell lung cancer in vitro.Progression-free survival at 2 years is a reliable surrogate marker for the 5-year survival rate in patients with locally advanced non-small cell lung cancer treated with chemoradiotherapy.Therapeutic management options for stage III non-small cell lung cancer.Radiation-induced esophagitis in lung cancer.A phase II open-label multicenter study of gefitinib in combination with irradiation followed by chemotherapy in patients with inoperable stage III non-small cell lung cancerA review of clinical trials of cetuximab combined with radiotherapy for non-small cell lung cancerInoperable stage III non-small cell lung cancer: Current treatment and role of vinorelbine.Role of surgery in N2 NSCLC: pros.Intervention quality is not routinely assessed in Cochrane systematic reviews of radiation therapy interventions.Therapeutic effect of 188Re-MAG3-depreotide on non-small cell lung cancer in vivo and in vitro.Cancer Care at Times of Crisis and War: The Syrian Example.
P2860
Q24187743-FB7D5CA9-ED39-4E47-B9C3-80CBB8473A97Q24234626-47738CC3-351E-4A56-825A-3A4DA47FB501Q28396577-FB2656A6-AED7-4DB0-8F26-ED4AC255B225Q29248583-B86AFA6E-F9BD-40A7-AE20-12ACAF1DAC15Q33412557-187C487F-FE75-4AE1-8088-53DAC7AAE612Q33435839-2AFEF463-4BB4-4984-BD3F-01FD561CB5A2Q33583923-F5C8B6F8-F161-4709-AE8A-3037C934F741Q33669810-36A50D61-830F-4824-A10E-A130747ECB8DQ33706852-DEF3F32D-FA4D-4A14-B9F6-71F172D30175Q33716531-BE1AA675-E721-4598-9E4B-04BEE8E9D4CFQ34041802-FE5EBACB-0470-41D7-A83A-85B8B6443A5DQ34044082-96CE85C4-D144-4DB8-B74F-33BD69A68EA7Q34389016-5CD5F03D-20D3-4BAF-9493-2A3EF1F22A36Q34672375-606B6A4C-0B63-49CC-AD1F-5595C9181373Q35072438-D94F8E27-95CC-4997-A38E-1674F754F994Q35190878-0063EA7A-832D-4F46-84A7-EBB5B264B3CDQ35200337-84FA29E8-B828-4392-B297-BE32507907FBQ35848165-FF6DF438-1E71-4015-92D8-D4AB44F539AFQ36051895-29363220-F16C-48D7-BD94-1C50677B809EQ36449810-33513C92-668C-4D78-BF3E-8A808C7B8BEBQ36657498-642F106E-875E-4B0B-B396-2F68670A50B0Q36708112-2CF1754C-DFA1-4E26-94FE-5011EE3270FEQ36855596-69801A6A-5DD0-47FE-B8D8-EE8284181B12Q36929934-AA3808D3-8407-4A25-8078-02D374732D86Q36946823-C5BBB8EB-410A-44BA-87B5-532B52AA858CQ37106816-3ADCDF16-BA16-4AC1-85EE-C0ED3817DB81Q37123650-1AB32F4F-5295-445A-AD3F-7F7764316D36Q37182205-5FB35D9C-C52B-49C9-B922-E5E59B135986Q37302306-83DD29B9-5EF6-4ED0-841D-B218B1DFB9DFQ37435103-4E432B28-0128-4910-99CF-2BD50C30847DQ37513753-C173ED3C-BFB9-4550-86BB-EF7E9CAB6BFAQ37642455-0BC56D7D-56B3-45D9-BC06-13B8179669C5Q37643563-E770F7B6-44B4-49FE-869F-A14B53F23EE1Q37716645-B78828F7-8CA2-4BB3-BFCF-FC91AE479578Q37975010-5C88A860-7DEF-4E32-B194-A2D329AD6833Q37977438-168BEB16-6E5B-4D11-BA5F-4BE5403CD8AFQ38961401-85DD75D4-E5FF-4241-88E3-30540CD8A732Q39094676-3A624655-4F71-41A9-B4AC-303966857BDDQ39194102-F99FD94F-DF85-4D3F-A286-7A99E33F41D0Q39214508-B05B42F9-55A1-4FA1-8587-9C7CBB3B24ED
P2860
Concurrent chemoradiotherapy in non-small cell lung cancer
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Concurrent chemoradiotherapy in non-small cell lung cancer
@ast
Concurrent chemoradiotherapy in non-small cell lung cancer
@en
Concurrent chemoradiotherapy in non-small cell lung cancer
@en-gb
Concurrent chemoradiotherapy in non-small cell lung cancer
@nl
type
label
Concurrent chemoradiotherapy in non-small cell lung cancer
@ast
Concurrent chemoradiotherapy in non-small cell lung cancer
@en
Concurrent chemoradiotherapy in non-small cell lung cancer
@en-gb
Concurrent chemoradiotherapy in non-small cell lung cancer
@nl
prefLabel
Concurrent chemoradiotherapy in non-small cell lung cancer
@ast
Concurrent chemoradiotherapy in non-small cell lung cancer
@en
Concurrent chemoradiotherapy in non-small cell lung cancer
@en-gb
Concurrent chemoradiotherapy in non-small cell lung cancer
@nl
P2093
P2860
P3181
P1476
Concurrent chemoradiotherapy in non-small cell lung cancer
@en
P2093
Fergus Macbeth
Noelle O'Rourke
Nuria Farré Bernadó
P2860
P3181
P356
10.1002/14651858.CD002140.PUB3
P50
P577
2010-06-16T00:00:00Z